[0001] This application for U.S. patent is filed as a utility application under U.S.C., Title 35, §111(a). [0002] This application for U.S. patent relates and claims priority to the following U.S. provisional applications, each of which was filed on Aug. 14, 2001: Ser. No. 60/312,114 and is entitled Methods of Administering Levothyroxine Pharmaceutical Compositions; Ser. No. 60/312,113 and is entitled Levothyroxine Compositions Having Unique Triiodothyronine Cmax Properties; Ser. No. 60/312,287 and is entitled Levothyroxine Compositions Having Unique Triidothyronine Plasma AUC Properties; Ser. No. 60/312,184 and is entitled Levothyroxine Compositions Having Unique Cmax Properties; Ser. No. 60/312,273 and is entitled Levothyroxine Compositions Having Unique Tmax Properties; Ser. No. 60/312,206 and is entitled Levothyroxine Compositions Having Unique Triiodothyronine Tmax Properties; Serial No. 60/312,289 and is entitled Unique Levothyroxine Aqueous Materials.
Number | Date | Country | |
---|---|---|---|
60312114 | Aug 2001 | US | |
60312113 | Aug 2001 | US | |
60312287 | Aug 2001 | US | |
60312184 | Aug 2001 | US | |
60312273 | Aug 2001 | US | |
60312206 | Aug 2001 | US | |
60312289 | Aug 2001 | US |